Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G W Price

Showing results (71-80 of 85) with videos related to

Pageof 9
Sort By:
British Journal of Pharmacology|May 12, 2000
[(3)H]-SB-269970--A selective antagonist radioligand for 5-HT(7) receptorsD R Thomas, P J Atkinson, M Ho, et al.
Journal of Neurochemistry|July 1, 1990
In vivo binding to peripheral benzodiazepine binding sites in lesioned rat brain: comparison between [3H]PK11195 and [18F]PK14105 as markers for neuronal damageG W Price, R G Ahier, S P Hume, et al.
British Journal of Pharmacology|October 17, 1998
SB-224289--a novel selective (human) 5-HT1B receptor antagonist with negative intrinsic activityJ V Selkirk, C Scott, M Ho, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|September 26, 1997
SB-216641 and BRL-15572--compounds to pharmacologically discriminate h5-HT1B and h5-HT1D receptorsG W Price, M J Burton, L J Collin, et al.
European Journal of Clinical Pharmacology|January 1, 1991
Measurement of human cerebral monoamine oxidase type B (MAO-B) activity with positron emission tomography (PET): a dose ranging study with the reversible inhibitor Ro 19-6327C J Bench, G W Price, A A Lammertsma, et al.
Genomics|December 9, 2000
Cloning and characterization of human NTT5 and v7-3: two orphan transporters of the Na+/Cl- -dependent neurotransmitter transporter gene familyM K Farmer, M J Robbins, A D Medhurst, et al.
Environmental Research|November 20, 2022
Critical review on phytoremediation of polyfluoroalkyl substances from environmental matrices: Need for global concernElaheh Kavusi, Behnaz Shahi Khalaf Ansar, Samira Ebrahimi, et al.
Cancer|April 1, 1992
Legal aspects, legislative effect, cost effectiveness, and barriers to breast cancer screeningR A Smith, B L Black, G W Price, et al.
British Journal of Pharmacology|August 6, 2000
Characterization of SB-271046: a potent, selective and orally active 5-HT(6) receptor antagonistC Routledge, S M Bromidge, S F Moss, et al.
Annals of the New York Academy of Sciences|February 3, 1999
The selective 5-HT1B receptor inverse agonist SB-224289, potently blocks terminal 5-HT autoreceptor function both in vitro and in vivoL M Gaster, P Ham, G F Joiner, et al.
Pageof 9

Showing results (71-80 of 85) with videos related to

Sort By:
Pageof 9
British Journal of Pharmacology|May 12, 2000
[(3)H]-SB-269970--A selective antagonist radioligand for 5-HT(7) receptorsD R Thomas, P J Atkinson, M Ho, et al.
Journal of Neurochemistry|July 1, 1990
In vivo binding to peripheral benzodiazepine binding sites in lesioned rat brain: comparison between [3H]PK11195 and [18F]PK14105 as markers for neuronal damageG W Price, R G Ahier, S P Hume, et al.
British Journal of Pharmacology|October 17, 1998
SB-224289--a novel selective (human) 5-HT1B receptor antagonist with negative intrinsic activityJ V Selkirk, C Scott, M Ho, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|September 26, 1997
SB-216641 and BRL-15572--compounds to pharmacologically discriminate h5-HT1B and h5-HT1D receptorsG W Price, M J Burton, L J Collin, et al.
European Journal of Clinical Pharmacology|January 1, 1991
Measurement of human cerebral monoamine oxidase type B (MAO-B) activity with positron emission tomography (PET): a dose ranging study with the reversible inhibitor Ro 19-6327C J Bench, G W Price, A A Lammertsma, et al.
Genomics|December 9, 2000
Cloning and characterization of human NTT5 and v7-3: two orphan transporters of the Na+/Cl- -dependent neurotransmitter transporter gene familyM K Farmer, M J Robbins, A D Medhurst, et al.
Environmental Research|November 20, 2022
Critical review on phytoremediation of polyfluoroalkyl substances from environmental matrices: Need for global concernElaheh Kavusi, Behnaz Shahi Khalaf Ansar, Samira Ebrahimi, et al.
Cancer|April 1, 1992
Legal aspects, legislative effect, cost effectiveness, and barriers to breast cancer screeningR A Smith, B L Black, G W Price, et al.
British Journal of Pharmacology|August 6, 2000
Characterization of SB-271046: a potent, selective and orally active 5-HT(6) receptor antagonistC Routledge, S M Bromidge, S F Moss, et al.
Annals of the New York Academy of Sciences|February 3, 1999
The selective 5-HT1B receptor inverse agonist SB-224289, potently blocks terminal 5-HT autoreceptor function both in vitro and in vivoL M Gaster, P Ham, G F Joiner, et al.
Pageof 9